Shire has made a €428 million offer for Belgium-based Movetis in a bid to grow its business in Europe and …
NICE has provisionally recommended Belgium-based Movetis’s Resolor as an option for the treatment of chronic constipation in women where laxatives …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer

